Table 2.
Multivariable analysis of clinical data, MC findings, and number of SNP-A aberrations.
| Factor | Hazard ratio (95% CI) | P |
|---|---|---|
| Age | 1.73 (0.75–4.07) | 0.002 |
| Sex (male vs. female) | 1.47 (1.01–1.69) | 0.007 |
| NEU (×109/L) (<0.8 vs. ≥0.8) | 1.19 (0.81–2.92) | 0.029 |
| Hb (g/L) (<80 vs. 80–100 vs. ≥100) | 1.52 (1.06–4.02) | 0.016 |
| Plt (×109/L) (<50 vs. 50–100 vs. ≥100) | 1.06 (0.58–1.52) | 0.030 |
| BM blasts (%) (<5 vs. 5–10 vs. >10) | 1.79 (1.04–3.47) | 0.016 |
| MC (very good, good, intermediate vs. poor, very poor) | 2.22 (0.79–6.12) | 0.008 |
| Number of SNP-A aberrations (≥3 vs. <3) | 2.40 (1.48–9.57) | 0.002 |
NEU, neutrophil; Hb, hemoglobin; Plt, platelet; BM, bone marrow; MC, metaphase cytogenetics; SNP-A, single nucleotide polymorphism array.